New at CADTH — October 2018

News and Events

CADTH is hosting two Medical Devices and Drug Portfolio Information Sessions on Thursday, November 1, 2018, from 9:30 a.m. to 12:00 p.m. and from 1:30 p.m. to 4:00 p.m. EDT, respectively. Interested participants can attend in person, at 150 King Street West, Toronto, or via webinar. This annual event is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio, and medical devices and clinical interventions portfolio. For more information and to register, please visit the CADTH events page.

Save the date. The 2019 CADTH Symposium is being held in Edmonton, Alberta, from April 14 to 16. Applications are also now open for abstract submissions and travels awards.

Drug Reimbursement Recommendations

CADTH recently issued the following CADTH Canadian Drug Expert Committee, or CDEC, Drug Reimbursement Recommendation:

• sebelipase alfa (Kanuma) for lysosomal acid lipase deficiency

CADTH Reports

CADTH recently completed the following reports:

Rapid Response Reports — Drug

• Regional Chemotherapy for the Treatment of Breast Cancer: Clinical and Cost-Effectiveness and Guidelines — Reference List
• Radioimmunotherapy Using 131-Iodine-8H9 for the Treatment of Central Nervous System Neoplastic Tumours: Clinical Effectiveness and Guidelines — Reference List
• Medical Cannabis Use in Palliative Care: Clinical Effectiveness and Guidelines — Summary of Abstracts
• Parenteral Nutrition Combination Products: Clinical Effectiveness, Cost-Effectiveness and Guidelines — Summary of Abstracts
• Methoxyflurane for Acute Pain in the Emergency Department: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines— Summary with Critical Appraisal
• Probiotics for Antibiotic-Associated Diarrhea and Clostridium difficile Infection: A Review of Guidelines— Summary with Critical Appraisal
• Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines— Summary with Critical Appraisal
• Substance Use in Breastfeeding Parents: A Review of Safety and Guidelines — Summary with Critical Appraisal
• Curosurf (poractant alfa) for the Treatment of Infants At Risk For or Experiencing Respiratory Distress Syndrome: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines— Summary with Critical Appraisal
• Benzydamine for Acute Sore Throat: A Review of Clinical Effectiveness and Guidelines — Summary with Critical Appraisal

Rapid Response Reports — Medical Devices and Systems

• Management of Complications During Hemodialysis: Guidelines — Reference List
• Coated Central Venous Catheters: Comparative Clinical Effectiveness and Safety — Summary of Abstracts
• Care of Adult Patients in Long-Term Care Who have Undergone a Laryngectomy: Clinical Evidence and Guidelines — Summary of Abstracts
• Australian Model of Rural Palliative Care: Clinical Evidence— Summary of Abstracts
• Laser Mediated Flapless Crown Lengthening: Clinical Effectiveness, Cost-Effectiveness, and Guidelines — Summary of Abstracts
• Photo-Activated Disinfection Therapy for Non-Dental Surgery: Clinical Effectiveness, Cost-Effectiveness, and Guidelines— Summary of Abstracts
• Magnetic Resonance Imaging for Prostate Assessment: A Review of Clinical and Cost-Effectiveness— Summary with Critical Appraisal
• Hyperbaric Oxygen Therapy for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Cost-Effectiveness — Summary with Critical Appraisal
• Counselling Provided by A Person with Religious Affiliation for Mental Health Disorders: A Review of Clinical Effectiveness and Guidelines — Summary with Critical Appraisal
• Patients’ Experiences with Cardiac Monitors for Stroke, Atrial Fibrillation, and Heart Failure: A Rapid Qualitative Review — Summary with Critical Appraisal

Rapid Response Reports — Other Diagnostics

• Diagnosing Perinatal Patients with Anxiety: Guidelines — Summary of Abstracts

Environmental Scan Reports

• Internet-Delivered Cognitive Behavioural Therapy for Major Depressive Disorder and Anxiety Disorders: An Environmental Scan

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.